Our Life Science Sector Expertise

The life sciences industry is one of the UK’s fastest-growing and most globally significant sectors — driving innovation in biotechnology, pharmaceuticals, diagnostics, medical devices, and digital health.

With a world-leading academic base, public institutions such as the NHS and MHRA, and an expanding network of private enterprises, the UK continues to lead scientific and healthcare innovation on a global stage.

At Myerson, we’re proud to support the companies, investors, and researchers who are shaping the future of life sciences.

Our specialist team works with clients across the full life sciences ecosystem - from research and development to manufacturing, investment, and delivery of healthcare solutions.

  • Research & Development - Collaboration and R&D agreements, confidentiality and IP ownership, licensing and tech transfer.
  • Manufacture & Supply - Contract manufacture, quality assurance, distribution, and agency agreements.
  • Regulatory & Compliance - Advice on MHRA and EMA regulations, medical device compliance, data protection, and marketing authorisations.
  • Investment & Growth - Fundraising, mergers and acquisitions, joint ventures, and strategic partnerships.
  • Employment & HR - Employment law and contractor management for laboratories, clinics, and medtech start-ups.
  • Property & Infrastructure - Acquisitions, leases, and development for laboratories, offices, and manufacturing facilities.
  • Resolve & Protect - Dispute resolution, IP enforcement, contractual disputes, and shareholder issues.
  • Support & Strengthen - In-house legal support via Myerson In-House+, providing flexible overflow resource and sector-specific insight.

Contact Our Life Sciences Solicitors

Life Science Lawyers

Who We Can Help

Our Life Sciences lawyers act for a wide range of clients operating across the healthcare, pharmaceutical, and biotechnology sectors, including:

  • Biotech companies developing therapeutics, vaccines, and diagnostics
  • Pharmaceutical manufacturers and distributors
  • MedTech and HealthTech start-ups building digital health platforms or connected medical devices
  • Clinical research organisations (CROs) and clinical trial sponsors
  • Universities and research institutions spinning out commercial ventures
  • Healthcare providers and private medical practices
  • Diagnostics and laboratory services companies
  • Investors and venture funds specialising in healthcare and life sciences
  • Suppliers, manufacturers and distributors supporting medical and research infrastructure
  • In-house legal teams seeking additional capacity and sector-specific expertise

Wherever you are in the innovation cycle, launching, scaling, partnering, or exiting, our team provides clear, commercially focused advice that helps you move forward with confidence.

Speak To Our Life Sciences Legal Experts

Carrying Out Legal Due Diligence in the Life Sciences Sector v2

Life Sciences Case Studies

Everything Genetic - Commercial Agreements

Client Intro

Everything Genetic predominantly supplies genetic tests for hereditary cancer and heart conditions.  During the COVID-19 pandemic, they also developed a product offering in respect of COVID-testing kits.

Case Overview

Over the course of our relationship with Everything Genetic we have supported and advised Everything Genetic on a variety of commercial agreements.  We have developed an in depth knowledge of the complex supply chains they use for the procurement of testing products and the delivery of outsourced testing and analysis services, which has allowed us to provide advice tailored to the client’s business in respect of the contracts governing their relationships with suppliers and customers. 

In particular, we have advised Everything Genetic on the terms of their agreement with a consortium of NHS hospital trusts for cancer testing services and development of an assay for the conduct of such testing.  The agreement involved collaborative research and development and required consideration of the intellectual property rights arising in respect of the new assay, their ownership and each parties’ rights of use, taking into account the respective contributions of the parties in respect of personnel, facilities and financial contribution.   We considered the interactions between the assay (and related pathology services) provided under this agreement, and Everything Genetic’s wider operations with the objective of achieving consistent treatment across the complex suite of related upstream and downstream contracts.

Richard Meehan, a Commercial specialist at Myerson Solicitors said:

Everything Genetic is a great example of why working for clients in the Life Sciences sector is so rewarding.  The complexity of the model – involving numerous third parties each contributing in a different way to the delivery of the final product – means that a diverse set of contracts need to be aligned in order to achieve the client’s objectives, which is an interesting challenge for the lawyers.  From a wider perspective, it is good to be able to contribute to the contractual structures which allow products like this to be delivered to end users who can achieve such positive health outcomes from their use. 

Locum360 - Platform Set Up

Client Intro

Locum360 is an online platform set up with the mission of helping GPs (and other practitioners) and medical practices to manage their arrangements in respect of temporary work placements. 

Case Overview

Our client, Dr Mohammed Noaman, has used his experience as a practising GP to design an online platform that reflects the requirements of GPs and the medical practices that engage them, allowing them to communicate about work opportunities, agree the details of specific engagements through the platform, and record the completion of the engagement, among a range of other functions. 

We provided guidance on legal issues relevant to the structure of these arrangements, and prepared the key online terms and conditions governing the basis on which the practitioners and the practices respectively use the Locum360 platform.

The arrangements between GPs and practices which are managed through the Locum360 platform, and the role played by Dr Noaman’s business in these arrangements, give rise to a range of legal considerations, including issues relating to the regulation of businesses that act as intermediaries in the employment sector.  Bespoke terms and conditions, developed through a process of close collaboration with the client, are designed to address those issues, and provide clarity about the respective contractual rights and obligations of the people using the Locum360 platform. 

Dr Noaman commented on his experience of working with Myerson on this matter:

Richard was incredibly knowledgeable and responsive throughout the entire process. He was able to quickly understand the specific needs of my company and drafted the T&Cs in a way that perfectly fit our requirements. He was always available to answer any questions or concerns that I had, and he was patient in explaining the legal jargon to me in terms that I could easily understand.

Working with Richard and the team at Myerson Solicitors was a great experience overall. They were professional, efficient, and went above and beyond to ensure that my company was fully protected. I would highly recommend their services to anyone in need of legal advice and assistance.

Richard Meehan, a Commercial specialist at Myerson Solicitors said:

Setting up an online platform that acts as channel of communication between two sets of potential counterparties – often buyers and sellers, but here GPs and medical practices – is always an interesting exercise.  There is a lot to think about, and careful drafting is needed to ensure that the terms and conditions give a clear and accurate description of how the platform works, and what the relationship of the different people involved will be. 

It has been a pleasure to support Dr Noaman in setting up Locum360 – from his personal experience he knows what matters to the users of the platform inside out, and it has been an enjoyable process to ensure that the drafting of the terms reflects those priorities.  It is good to have had the opportunity to contribute to a tool that has the potential to make the lives of medical practitioners, and the practices that engage them, a little easier, and we wish Dr Noaman every success with the new business.

Phoenix Rehabilitation Services - Share Purchase Agreement

Client Intro

Our clients in this corporate transaction were the shareholders in Phoenix Rehabilitation Services Limited and its subsidiary, Pace Rehabilitation Limited to an off-shore buyer, and transaction relatied to the sale of the entire issued share capital of those companies.

Case Overview

The work undertaken included an in-depth due diligence exercise due to the medical nature of the target entity; this included consideration into the Medical Device Directive and medical regulatory authorities. The due diligence exercise led to a thorough review of the target’s GDPR processes and advise in relation to the same. Myerson further advised on disclosure and preparing the disclosure letter, negotiating the share purchase agreement, ancillary documentation and tax deed. The transaction also required employment and property support.

This transaction involved additional complexities which meant that we had to amend the terms of the deal to reflect the change from a simultaneous exchange and completion to a split exchange and completion of the sale.  This was due to a competition market authority issue which became a condition of completion. It was a condition of completion for the CMA to determine whether the transaction constituted a relevant merger situation within the meaning of the Part 3 of the Enterprise Act 2002.

Morelife (UK) Ltd - Sale of Business

Client Intro

We acted for the shareholders of Morelife (UK) Ltd, a UK-based provider of healthy lifestyle, weight management and wellbeing services to NHS organisations, integrated care boards and private clients.

 

Case Overview

We advised on the sale of Morelife (UK) Ltd to Menwell Ltd t/a Voy, supporting the shareholders through all stages of the transaction.

The deal structure combined an initial payment with longer-term value linked to the future performance of the business, alongside an ongoing equity interest in the acquiring group. This required careful alignment between legal documentation and tax advice to ensure the structure delivered the intended commercial outcome for the shareholders.

Particular complexity arose from the company’s share and option arrangements, which required detailed analysis to ensure the proceeds were allocated fairly and in accordance with existing rights while remaining compliant with tax requirements.

We worked closely with the shareholders and their advisers throughout to navigate these issues and deliver a successful transaction.

 

“This was a significant transaction for the shareholders, and our focus was on delivering a structure that worked in practice as well as on paper. Close collaboration and clear commercial thinking were key throughout.” – Chris Moss, Partner

Why Choose Myerson's Life Sciences Lawyers

Our lawyers have extensive experience advising clients across the life sciences and healthcare sectors, from early-stage innovators to established global enterprises.

We understand the unique challenges in IP protection, regulatory compliance, product development, and data governance, and deliver tailored, practical advice designed to help your business grow.

We collaborate with your leadership or legal team to deliver commercially sound solutions that keep your science moving forward.

  • Top Tier ranked in The Legal 500 (North West)
  • Over 20 years’ experience advising across biotech, pharma, medtech, and healthcare sectors
  • Multi-disciplinary expertise across corporate, commercial, IP, employment, property, and disputes
  • Partner-led service with transparent pricing and responsive support
  • Trusted by founders, investors, and in-house counsel nationwide

Contact Our Lawyers

commercial team photo 2 v2

Meet Our Life Sciences Solicitors

Richard M

Richard Meehan

Richard is a Partner in our Corporate Commercial Team

Sarah Dabek v3

Sarah Dabek

Sarah is an Senior Associate in our Commercial Property Team

Luke W final

Luke Wilkins

Luke is an Associate in our Corporate Commercial Team

Contact Our Life Sciences Lawyers

Complete the form below or alternatively you can call Myerson Solicitors on:

0161 941 4000

Latest Life Sciences News & Insights


Research & Development Agreements: Key Legal and Commercial Issues
Blog

Research & Development Agreements: Key Legal and Commercial Issues

Research and Development (R&D) Agreements play a key role in enabling organisations to pool expertise and resources to develop new products or processes.  Agreements of this nature are commonly used between commercial entities and academic institutions, and play a key role in establishing the funding models under which research takes place. With...

Read Blog
7 minutes reading time
Commercial | 16 February 2026
Life Sciences in the UK – An End of Year Update for 2024
Blog

Life Sciences in the UK – An End of Year Update for 2024

In this blog, our Life Science Solicitors consider the state of play for the Life Sciences sector in the UK as 2024 draws to a close by providing an update on developments regarding the schemes and initiatives we have discussed throughout the year.   

Read Blog
5 minutes reading time
Life Sciences | 17 December 2024
Opportunities and Challenges of Using AI In Medical Research
Blog

Opportunities and Challenges of Using AI In Medical Research

The Government has recently announced its plans to invest £6.4 million in an Artificial Intelligence (AI) digital pathology data platform , with the particular aim of (1) storing digital pathology data from the NHS and (2) training AI models on this set of information to help improve the identification and treatment of diseases. The programme is...

Read Blog
4 minutes reading time
Commercial Litigation | 29 October 2024
Employment Status in the Life Sciences Sector: A New Dawn
Blog

Employment Status in the Life Sciences Sector: A New Dawn

In recent years, working models have become increasingly varied, with organisations routinely departing from traditional employee/employer arrangements. This is particularly the case for the life sciences industry, which, given the work's project-driven nature, has historically relied upon consultant and contractor staff. Our Life Sciences and...

Read Blog
5 minutes reading time
Employment | 18 September 2024
Life Sciences and Commercial Real Estate: A Growing Synergy
Blog

Life Sciences and Commercial Real Estate: A Growing Synergy

The life sciences sector has emerged as a significant driver of innovation and economic growth in recent years. With advancements in biotechnology, pharmaceuticals, medical devices and healthcare services, the life sciences industry is improving human health and transforming the landscape of commercial real estate. Our Life Sciences and...

Read Blog
4 minutes reading time
Commercial Property | 16 July 2024
Carrying Out Legal Due Diligence in the Life Sciences Sector
Blog

Carrying Out Legal Due Diligence in the Life Sciences Sector

Due diligence is essential to any business (or company) purchase, particularly in the life sciences sector. It allows the buyer to obtain information relating to the business to manage the risk caused by the buyer-beware principle.  The due diligence process begins at the start of the transaction and is likely to continue throughout the...

Read Blog
5 minutes reading time
Life Sciences | 24 June 2024